Total Funding
33
59
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
188746
Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers.
- Tim Schober: CEO
About the Company
Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers. Our peptide therapeutics are modified by photoisomerizable building blocks that can toggle between inactive and active forms. Biological activity is switched “on” with non-thermal red light irradiation in the site of tumors, avoiding
side-effects in the healthy tissues. Unique MOA of membrane-active peptides avoids resistance development and activates innate immune system.
